Sitagliptin + Metformin XR Tablets bulk supplier for pharma manufacturers

Sitagliptin + Metformin Xr Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100/1000 mg

Reference Brands: Janumet XR (US & EU)

Category: Diabetes

Sitagliptin + Metformin XR Tablets is available in Tablets and strengths such as 100/1000 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sitagliptin + Metformin XR Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Sitagliptin + Metformin XR Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Sitagliptin + Metformin XR tablets, approved by the FDA (USA) and regulated by the EMA (EU), are indicated for the management of Type 2 diabetes when monotherapy fails. Brands like Janumet XR offer extended glycemic control with once-daily dosing. These tablets must meet stringent bioequivalence, GMP, and pharmacovigilance standards in both markets. EU guidelines require SmPC-compliant labeling and risk management plans. The combination enhances patient adherence and reduces glucose levels effectively. Pharmatradz.com, a global B2B pharmaceutical marketplace, connects buyers with trusted USFDA and EU-GMP certified manufacturers for bulk procurement of Sitagliptin + Metformin XR and other diabetes treatments.

Frequently Asked Questions

Yes, Sitagliptin + Metformin XR Tablets is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Sitagliptin + Metformin XR Tablets is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Premixed Insulins (70/30, 50/50) Injectable

Strength:
U-100

Form: Vials, pens

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

View Details
Insulin Lispro (Humalog) Injectable

Strength:
U-100, U-200

Form: Vials/pens

Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)

View Details
Insulin Aspart (Novolog) Injectable

Strength:
U-100, U-200

Form: Vials/pens

Reference Brands: Novolog, Fiasp(US &EU)

View Details
Insulin Glargine (Lantus) Injectable

Strength:
U-100, U-300

Form: Vials/pens

Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.